| [1] |
LU Juping, HU Jun, DENG Yongming, LIAO Shufang.
Downregulation of FKBP4 inhibits the malignant progression of non-small cell lung cancer by blocking the PI3K/Akt/mTOR signaling pathway
[J]. Journal of Practical Oncology, 2025, 39(3): 184-190.
|
| [2] |
GUO Xueyun, XU Yunfeng, CHU Shangqi, RUAN Fuxiang.
The correlation between EGF gene polymorphism and sensitivity of concurrent chemoradiotherapy regimen containing cisplatin in esophageal cancer patients
[J]. Journal of Practical Oncology, 2025, 39(3): 216-223.
|
| [3] |
WU Dan, WANG Yihai.
Current status of radiotherapy resistance research in breast cancer
[J]. Journal of Practical Oncology, 2025, 39(3): 262-266.
|
| [4] |
WANG Mengfei, XU Boqun.
Advances in immunotherapy for locally advanced cervical cancer
[J]. Journal of Practical Oncology, 2025, 39(2): 157-161.
|
| [5] |
LI Caizheng, ZHENG Jing, SU Qiaoli.
Advance progress in immunotherapy for unresectable locally advanced non-small cell lung cancer
[J]. Journal of Practical Oncology, 2025, 39(1): 67-72.
|
| [6] |
HAO Huiting, ZHAO Huijuan, XU Qiaohui.
Expression and clinical significance of hypermethylated in cancer 1 in non-small cell lung cancer
[J]. Journal of Practical Oncology, 2024, 38(5): 306-312.
|
| [7] |
XU Lingyan, LI Qianni, LI Jian, YAO Xuepei, LIU Meina.
Analysis for the impact of the first hospitalization days on treatment quality in patients with non-small cell lung cancer
[J]. Journal of Practical Oncology, 2024, 38(4): 221-226.
|
| [8] |
YAO Xuepei, BAI Shanqi, LIU Meina.
Analysis of factors influencing treatment quality of non-small cell lung cancer based on causal diagram model
[J]. Journal of Practical Oncology, 2024, 38(4): 227-234.
|
| [9] |
LI Jian, LI Qianni, XU Lingyan, YAO Xuepei, LIU Meina.
Research on the causal effects of non-small cell lung cancer treatment process on in-hospital mortality based on double robust estimation method
[J]. Journal of Practical Oncology, 2024, 38(4): 235-240.
|
| [10] |
CHENG Yongming, DONG Huanhuan, XU Hui.
Hsa-let-7b-5p inhibits proliferation,migration and invasion in non-small cell lung cancer
[J]. Journal of Practical Oncology, 2024, 38(3): 157-167.
|
| [11] |
ZHANG Xuan, LI Xin, ZHAO Kang.
Relationship between serum inflammatory markers and prognosis of advanced non-small cell lung cancer patients treated with first-line immunosuppressants
[J]. Journal of Practical Oncology, 2024, 38(1): 37-44.
|
| [12] |
FENG Churan, CAO Jianzhao, CHEN Ziyin, ZHANG Daxin, LU Hailing.
Research progress on radiation-induced cardiac injury in breast cancer and its preventive measures
[J]. Journal of Practical Oncology, 2023, 37(6): 513-518.
|
| [13] |
XUE Liangfang, WANG Xinshu, ZHANG Yunyan, CHENG Haiyan, JIN Hong, WANG Yaoxian, YANG Shanshan, LI Qi.
A comparative study on the efficacy and adverse reactions of nituzumab and bevacizumab combined with synchronous radiotherapy and chemotherapy in the treatment of locally advanced cervical cancer
[J]. Journal of Practical Oncology, 2023, 37(5): 416-421.
|
| [14] |
MIAO Ling, ZHAO Zhihan, WANG Min.
Levels and clinical significance of PA28γ and miR-7-5p in tumor tissues of patients with non-small cell lung cancer
[J]. Journal of Practical Oncology, 2023, 37(4): 344-350.
|
| [15] |
XIANG Di, KOU Lina, DU Chunling, OU Xiaowen, CHEN Tiejun.
Research progress on the relationship between systemic immune inflammatory index and prognosis of colorectal cancer
[J]. Journal of Practical Oncology, 2023, 37(4): 377-382.
|